Thrombosis and Haemostasis

LinksSchließen

Referenz

Ogiwara K, Nogami K, Matsumoto T, Shima M.
Tissue factor pathway inhibitor in activated prothrombin complex concentrates (aPCC) moderates the effectiveness of therapy in some severe hemophilia A patients with inhibitor.

Int J Hematol 2014;
99 (05) 577-587

Bibliographische Angaben herunterladen

Aufrufen in: